Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STEAP2 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
STEAP2 - Prostate cancer
STEAP2 - Androgen deprivation effect on LNCaP prostate cancer cells: time course
STEAP2 - Prostate cancer progression at the cellular level
STEAP2 - Androgen response element specific DNA-binding polyamide effect on dihydrotestoterone-stimulated prostate cell line
STEAP2 - Metastatic prostate cancer (HG-U95B)
GEO DataSets Gene Chromosome neighbors Homologene neighbors
STEAP2 - c-MYC depletion effect on carcinoma cell lines
STEAP2 - Androgen receptor modulator effect: time course (HG-U133B)
STEAP2 - Prostate cancer progression
STEAP2 - Crohn disease and ulcerative colitis comparison
STEAP2 - Normal human tissue expression profiling (HG-U95E)
STEAP2 - Peptidyl-prolyl cis/trans isomerase Pin1 deficiency effect on prostate cancer cells
STEAP2 - High grade prostate cancer
STEAP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
STEAP2 - Late passage LNCaP prostate tumor cells treated with androgen receptor shRNA or androgen R1881
STEAP2 - Prostate cancer cell line response to dihydrotestosterone: time course
STEAP2 - Prostate adenocarcinoma response to radiation (HG-U95E)
STEAP2 - Prostate adenocarcinoma response to radiation (HG-U95B)
STEAP2 - Dasatinib-resistant and dasatinib-sensitive pancreatic cancer cell lines
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on